Cargando…

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters

Relevance of blood-based biomarkers is increasing into the neurodegenerative diseases field, but data on Parkinson's disease (PD) remain still scarce. In this study, we used the SiMoA technique to measure serum content of total tau protein and amyloid-β peptides (Aβ-42, Aβ-40) in 22 PD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schirinzi, Tommaso, Zenuni, Henri, Grillo, Piergiorgio, Bovenzi, Roberta, Guerrera, Gisella, Gargano, Francesca, Pieri, Massimo, Bernardini, Sergio, Biagio Mercuri, Nicola, Battistini, Luca, Sancesario, Giulia Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914101/ https://www.ncbi.nlm.nih.gov/pubmed/35280296 http://dx.doi.org/10.3389/fneur.2022.748599

Ejemplares similares

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Effects of head trauma and sport participation in young-onset Parkinson’s disease
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson’s Disease
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction
por: Schirinzi, Tommaso, et al.
Publicado: (2023)

Alpha-Klotho in Parkinson’s disease: a perspective on experimental evidence and potential clinical implications
por: Grillo, Piergiorgio, et al.
Publicado: (2022)

Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG
por: Conti, Matteo, et al.
Publicado: (2022)

Adult-onset sporadic chorea: real-world data from a single-centre retrospective study
por: Bovenzi, Roberta, et al.
Publicado: (2021)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort
por: Bovenzi, Roberta, et al.
Publicado: (2023)

One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
por: Sambucci, Manolo, et al.
Publicado: (2019)

STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson’s Disease
por: Conti, Matteo, et al.
Publicado: (2022)

Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
por: Lattanzi, Roberta, et al.
Publicado: (2019)

Cortical microstructural associations with CSF amyloid and pTau
por: Nir, Talia M., et al.
Publicado: (2023)

Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study
por: Gnarra, Oriella, et al.
Publicado: (2023)

Centrality of Early Synaptopathy in Parkinson’s Disease
por: Imbriani, Paola, et al.
Publicado: (2018)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

Blood–Brain Barrier Dysfunction and Aβ42/40 Ratio Dose-Dependent Modulation with the ApoE Genotype within the ATN Framework
por: Toniolo, Sofia, et al.
Publicado: (2023)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction
por: Di Lazzaro, Giulia, et al.
Publicado: (2018)

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
por: Chiurchiù, Valerio, et al.
Publicado: (2022)

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
por: Cariulo, Cristina, et al.
Publicado: (2019)

Friedreich ataxia in COVID-19 time: current impact and future possibilities
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
por: Wang, Qing, et al.
Publicado: (2018)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Elevated CSF GAP-43 is Alzheimer’s disease specific and associated with tau and amyloid pathology
por: Sandelius, Åsa, et al.
Publicado: (2018)

Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds
por: Remnestål, Julia, et al.
Publicado: (2021)

EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS
por: Guerrera, Gisella, et al.
Publicado: (2020)

Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
por: Oh, Esther S., et al.
Publicado: (2018)

Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers
por: Salvadó, Gemma, et al.
Publicado: (2022)

β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
por: Kumar, Atul, et al.
Publicado: (2022)

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
por: Maftei, Daniela, et al.
Publicado: (2022)

Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [(18)F]-Flutemetamol PET Scan Result
por: Westwood, Sarah, et al.
Publicado: (2018)

Correction: Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
Publicado: (2018)

Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cspglc9e87g203van21tpbbrcv